From Other Journals: A Review of Recent Articles in Pediatric Cardiology

Tarek Alsaied1,2, Awais Ashfaq3,4

  • 1Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. tarek.alsaied@cchmc.org.

Pediatric Cardiology
|September 4, 2020
PubMed

Insights

This review summarizes recent pediatric cardiology research, highlighting promising pulmonary valve repair, Losartan for Marfan syndrome, and outcomes in adults with congenital heart disease. It also covers Fontan operation risks, COVID-19 related multisystem inflammatory syndrome in children, and cardiac transplant risks.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiovascular Research

Background:

  • Recent advancements in pediatric cardiology require synthesis for clinical application.
  • Keeping abreast of emerging research is crucial for pediatric cardiologists.
  • This review consolidates key findings from recent publications in the field.

Purpose of the Study:

  • To provide a concise summary of significant recent articles relevant to pediatric cardiologists.
  • To highlight novel techniques and findings in pediatric cardiovascular medicine.
  • To facilitate awareness of the latest research impacting clinical practice.

Main Methods:

  • Review of recently published articles in pediatric cardiology journals.
  • Synthesis of findings related to specific cardiovascular conditions and treatments.
  • Categorization of research into key areas of clinical significance.

Main Results:

  • Pulmonary valve repair shows promise for tetralogy of Fallot and pulmonary stenosis.
  • Losartan may reduce aortic root dilation in Marfan syndrome.
  • Adults with congenital heart disease exhibit diverse characteristics across the USA.
  • Right ventricular morphology and atrioventricular valve regurgitation predict outcomes post-Fontan operation.
  • Ventricular dysfunction is common in pediatric COVID-19 related multisystem inflammatory syndrome.
  • Modifiable risk factors increase post-cardiac transplant risks.

Conclusions:

  • Emerging techniques and treatments offer new hope for pediatric cardiac patients.
  • Understanding patient characteristics and risk factors is key to improving outcomes.
  • Continued research is vital for advancing the care of children with heart conditions.

Related Concept Videos

Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
The Cardiac Cycle01:13

The Cardiac Cycle

The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and empty blood into the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...